https://staging.captis.com/wp-content/uploads/2021/04/fb_image-1125.jpeg8501280CAPTIShttps://staging.captis.com/wp-content/uploads/2021/01/captis_full_large.pngCAPTIS2021-04-05 02:00:242021-04-05 02:53:08AbbVie announces extension of USFDA review period for Rinvoq sNDA
https://staging.captis.com/wp-content/uploads/2021/04/fb_image-75.jpeg6491280CAPTIShttps://staging.captis.com/wp-content/uploads/2021/01/captis_full_large.pngCAPTIS2021-04-01 02:02:282021-04-01 03:15:55Takeda Pharmaceutical concludes sale of OTC and non-core assets to Orifarm for $670m
https://staging.captis.com/wp-content/uploads/2021/03/fb_image-3399.jpeg10801533CAPTIShttps://staging.captis.com/wp-content/uploads/2021/01/captis_full_large.pngCAPTIS2021-03-31 01:52:282021-03-31 03:11:09Amgen agrees to acquire biopharmaceutical company Rodeo Therapeutics
https://staging.captis.com/wp-content/uploads/2021/03/fb_image-900.jpeg6191100CAPTIShttps://staging.captis.com/wp-content/uploads/2021/01/captis_full_large.pngCAPTIS2021-03-26 05:46:162021-03-26 06:30:42EMA validates Gilead Sciences’ application for breast cancer therapy